على هذه الصفحة
ALGN Align Technology, Inc. - Common Stock
NASDAQ · Health Care · عرض على SEC EDGAR ↗ إغلاق أكتوبر 2, 2026 10-K/10-Q أغسطس 5, 2026
$143,74
· % من نطاق 52 أسبوعًا
· فوق الحد الأدنى
· إلى مرتفع
$124,91أدنى 52 أسبوعًا
$200,44أعلى 52 أسبوعًا
القيمة السوقية (الربع الأخير)
$10.24B
P/E (سنوي حالي)
25.0
ربح السهم (سنوي حالي)
$5.74
الإيرادات (سنوي حالي)
$4.14B
شاراتك
نطاق 52 أسبوعًا
$125–$200
تقييم المحللين
BUY
السعر المستهدف
$206
P/E
25.0
ROE
10.2%
هامش صافي الربح
10.0%
شريط الشارات الخاص بك فارغ — قم بتثبيت مقياس في أي مكان على هذه الصفحة.
ALGN لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
السعر
$143.74
القيمة السوقية (الربع الأخير)
$10.24B
P/E (سنوي حالي)
25.0
ربح السهم (سنوي حالي)
$5.74
الإيرادات (سنوي حالي)
$4.14B
ROE (سنوي حالي)
10.2%
نطاق 52 أسبوعًا
$125–$200
ALGN مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
نطاق
أشرطة
تتكيف دقة الشريط مع الفترة المحددة - مرر مؤشر الفأرة فوق الرسم البياني لرؤية الافتتاح/الأعلى/الأدنى/الإغلاق للشريط.
حول Align Technology, Inc. - Common Stock نظرة عامة على الشركة من ويكيبيديا
Align Technology, Inc. is an American manufacturer of 3D digital scanners and Invisalign clear aligners used in orthodontics and restorative workflow. It was founded in 1997 and is headquartered in Tempe, Arizona. The company manufactures the aligners in Juarez, Mexico, and its scanners in Israel and China. The company is best known for its Invisalign system, which is a clear aligner treatment used to straighten teeth.
Invisalign
Invisalign is a brand of clear aligners manufactured by Align Technology. The clear align system had been used to treat more than 18 million patients by 2017, and 22 million patients by 2026.
Align Technology founder Zia Chishti conceived of the basic design of Invisalign while an adult orthodontics patient. During his treatment with a retainer intended to complete his treatment, he posited that a series of such devices could effect a large final placement in a series of small movements. He partnered with Kelsey Wirth to seek developers.
Invisalign was approved by the Food and Drug Administration in 1998, and sales began in the U.S. in 1999. Orthodontists were resistant to adopting Invisalign at first, in particular because the founders had no orthodontic credentials or expertise, but the product became popular among consumers. The company raised about $140 million in funding over four rounds from 1997 to 2000. In 2000 Align Technology planned a $31 million television advertising campaign that The New York Times said would be "the most aggressive consumer advertising plan the dental profession has ever seen". In 2001, $130 million in additional funding was raised through an initial public offering on NASDAQ. By 2001, 75 percent of the 8,500 orthodontists in North America had been trained on the Invisalign system. That same year, Align Technology made Invisalign available to general dentists following a class-action lawsuit that alleged making the system available only to orthodontists resulted in unfair competition for dentists.
In the early 2000s, Align Technology was spending nearly all of its revenues on marketing and advertising, and losing about $18 million per year. Cofounders Wirth and Chishti resigned from Align Technology in 2001 and 2003 respectively, with Thomas Prescott replacing Chishti as CEO in March 2002. Prescott re-focused the company on North America and cut the marketing budget to about one-third its original size.
The Invisalign system grew from 80,000 patients in 2002 to 175,000 in 2004. It won several awards for stereolithography, medical design and fast growth. Align Technology was profitable for the first time in 2003. In 2005 the company expanded into Japan, and acquired General Orthodontic, an orthodontics firm that supported doctors prescribing the Invisalign system. Later that year, the Harvard School of Dental Medicine began requiring that its orthodontic graduate students complete Invisalign certification before they graduate.
The Invisalign Express 10, which uses 10 aligners, was introduced in 2005. Invisalign 1.5 was released in 2009. It was followed by Invisalign G3 in 2010 and G4 in 2011. Invisalign G3 and G4 were designed for more complex treatments. An Invisalign Express 5 version, which uses 5 aligners, was introduced in 2012. In February 2014, Align Technology released a G5 product designed to treat deep bites.
Support, software engineering, pre-production and administrative functions are done from Align Technology's headquarters in California. The manufacturing of Invisalign aligners is performed in Mexico, and treatment plans are created in Costa Rica. Align Technology also operates separate subsidiaries in Hong Kong and Australia that sell Invisalign in their respective markets. Align Technology provides training and certification to doctors.
In 2007 the Academy of General Dentistry approved Align Technology's Program Approval for Continuing Education (PACE) program. The company also created the AlignTech Institute, which provides educational resources to doctors. In March 2011 Align Technology acquired Cadent System, Inc., a dentist firm, for $190 million.
A major revision to the manufacturing process was started in 2026, a switch from mold-based appliance manufacture to 3D-printing, aimed at reducing the cost and complexity of the manufacturing process through disintermediation.
History
Align Technology was founded in 1997 by Zia Chishti and Kelsey Wirth, classmates at Stanford Graduate School of Business, and began working on the development of a clear aligner. Align received FDA clearance to market the Invisalign system in 1998, and it was first marketed in 2000. Align Technology went public on January 26, 2001, on the Nasdaq Stock Market.
In March 2011 Align acquired the Israeli company Cadent for $190 million; Cadent manufactured intraoral scanners that included 3D imaging, as well as software to display the acquired images and to plan treatment.
Joseph M. Hogan joined Align in June 2015, and is CEO and president.
The company's sales reached $1 billion for the first time in 2016 and its products were being used in about 8% of people who got braces. In 2017 the company was faced with the challenge of the expiration of its patents on its Invisalign system starting in October 2017 and the beginning of generic competition.
In March 2020, Align Technology announced that it has signed a definitive agreement to acquire exocad Global Holdings for approximately $418.7 million.
As of February 2023, Align Technology has assisted over 234,000 doctors and over 14.5 million patients worldwide.
In September 2023, it was announced Align Technology had acquired the Vienna-headquartered 3D printing technology and materials company, Cubicure GmbH.
المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗
قطاعHealth Care
صناعةHealth Care
موظفون20435
بلدUS
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
الإيرادات$4.03B2016-12-31 → 2025-12-31
ربح السهم$5.652016-12-31 → 2025-12-31
التدفق النقدي الحر$491M2016-12-31 → 2025-12-31
هامش صافي10.0%2016-12-31 → 2025-12-31
التقييم والنسب
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
| المقياس | اتجاه 5 سنوات | ALGN | متوسط 5 سنوات | متوسط الأقران | الحكم |
|---|---|---|---|---|---|
| P/E (سنوي حالي) | 25.0متوسط 5 سنوات ≈45.1 | ≈45.1 | 28.5 | مبالغ في تقييمه | |
| السعر/المبيعات (سنوي حالي) | 2.5متوسط 5 سنوات ≈5.9 | ≈5.9 | 2.1 | مبالغ في تقييمه | |
| السعر / القيمة الدفترية (الربع الأخير) | 2.4متوسط 5 سنوات ≈6.2 | ≈6.2 | 2.1 | مبالغ في تقييمه | |
| السعر / التدفق النقدي الحر (سنوي حالي) | 16.2متوسط 5 سنوات ≈41.4 | ≈41.4 | · | · | |
| السعر / التدفق النقدي (سنوي حالي) | 13.6متوسط 5 سنوات ≈27.7 | ≈27.7 | 17.6 | مبالغ في تقييمه | |
| السعر / القيمة الدفترية الملموسة (الربع الأخير) | 2.5متوسط 5 سنوات ≈7.3 | ≈7.3 | · | · |
يتم حساب الوسيط النظير على أساس موحد لكل مقياس وقد لا يتطابق دائمًا مع الأساس السنوي الحالي/الربع الأخير المعروض لهذا السهم.
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
| المقياس | اتجاه 5 سنوات | ALGN | متوسط 5 سنوات | متوسط الأقران | الحكم |
|---|---|---|---|---|---|
| هامش الربح الإجمالي (سنوي حالي) | 68.0%متوسط 5 سنوات ≈70.4% | ≈70.4% | 58.2% | من الدرجة الأولى | |
| هامش التشغيل (سنوي حالي) | 13.2%متوسط 5 سنوات ≈17.5% | ≈17.5% | 11.8% | من الدرجة الأولى | |
| هامش EBITDA (سنوي حالي) | 19.4%متوسط 5 سنوات ≈21.3% | ≈21.3% | 17.6% | متوافق | |
| هامش ما قبل الضريبة (سنوي حالي) | 13.7%متوسط 5 سنوات ≈17.6% | ≈17.6% | 10.1% | من الدرجة الأولى | |
| هامش صافي الربح (سنوي حالي) | 10.0%متوسط 5 سنوات ≈12.3% | ≈12.3% | 6.7% | من الدرجة الأولى | |
| العائد على الأصول (سنوي حالي) | 6.5%متوسط 5 سنوات ≈8.2% | ≈8.2% | 3.5% | من الدرجة الأولى | |
| ROE (سنوي حالي) | 10.2%متوسط 5 سنوات ≈12.9% | ≈12.9% | 6.5% | من الدرجة الأولى | |
| ROIC | 9.4%متوسط 5 سنوات ≈12.8% | ≈12.8% | 5.1% | من الدرجة الأولى |
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
| المقياس | اتجاه 5 سنوات | ALGN | متوسط 5 سنوات | متوسط الأقران | الحكم |
|---|---|---|---|---|---|
| النسبة الحالية (الربع الأخير) | 1.4متوسط 5 سنوات ≈1.3 | ≈1.3 | 1.7 | سيولة منخفضة | |
| Quick Ratio (النسبة السريعة) | 1.1متوسط 5 سنوات ≈1.0 | ≈1.0 | 0.5 | سيولة قوية |
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
| المقياس | اتجاه 5 سنوات | ALGN | متوسط 5 سنوات | متوسط الأقران | الحكم |
|---|---|---|---|---|---|
| Revenue YoY (الإيرادات مقارنة بالعام السابق) | 0.90%متوسط 5 سنوات ≈12.4% | ≈12.4% | · | · | |
| Revenue CAGR 3Y (معدل نمو الإيرادات السنوي المركب لـ 3 سنوات) | 2.6%متوسط 5 سنوات ≈6.3% | ≈6.3% | · | · | |
| Revenue CAGR 5Y (معدل نمو الإيرادات السنوي المركب لـ 5 سنوات) | 10.3% | · | · | · | |
| EPS YoY (ربحية السهم على أساس سنوي) | 0.53%متوسط 5 سنوات ≈-17.2% | ≈-17.2% | · | · | |
| Net Income YoY (صافي الدخل مقارنة بالعام السابق) | -2.6%متوسط 5 سنوات ≈-18.9% | ≈-18.9% | · | · | |
| EPS CAGR 3Y (متوسط نمو ربحية السهم السنوي لـ 3 سنوات) | 7.0%متوسط 5 سنوات ≈-15.3% | ≈-15.3% | · | · | |
| EPS CAGR 5Y (متوسط نمو ربحية السهم السنوي لـ 5 سنوات) | -24.1% | · | · | · | |
| Net Income CAGR 3Y (متوسط نمو صافي الدخل السنوي لـ 3 سنوات) | 4.3%متوسط 5 سنوات ≈-17.0% | ≈-17.0% | · | · | |
| Net Income CAGR 5Y (متوسط نمو صافي الدخل السنوي لـ 5 سنوات) | -25.4% | · | · | · |
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
| المقياس | اتجاه 5 سنوات | ALGN | متوسط 5 سنوات | متوسط الأقران | الحكم |
|---|---|---|---|---|---|
| Asset Turnover (دوران الأصول) | 0.6متوسط 5 سنوات ≈0.7 | ≈0.7 | 0.6 | متوافق | |
| Inventory Turnover (دوران المخزون) | 5.5متوسط 5 سنوات ≈4.6 | ≈4.6 | 2.7 | من الدرجة الأولى | |
| Receivables Turnover (دوران المستحقات) | 3.8متوسط 5 سنوات ≈4.4 | ≈4.4 | 7.7 | ضعيف | |
| Revenue / Employee (الإيرادات / الموظف) | ≈$197.5K | · | · | · |
القيمة · ≈ متوسط 5 سنوات · متوسط الصناعة · حكم مقارنة بالمتوسط
سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
متوسط المفاجأة
4.2%
التقرير القادم
أكتوبر 28, 2026
| الفترة | تقرير | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|---|
| 30 يونيو، 2026 | يوليو 29, 2026 | $2.64 | $2.66 | -0.87% |
| 31 مارس، 2026 | $2.58 | $2.33 | 11.0% | |
| 31 ديسمبر، 2025 | $3.29 | $3.03 | 8.5% | |
| 30 سبتمبر، 2025 | $2.61 | $2.45 | 6.5% | |
| 30 يونيو، 2025 | $2.49 | $2.62 | -5.0% | |
| 31 مارس، 2025 | $2.13 | $2.02 | 5.2% |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.03B | $4.00B | $3.86B | $3.73B | $3.95B | $2.47B | $2.41B | $1.97B | $1.47B | $1.08B | $845M | $762M | |
| Cost of Revenue | $1.32B | $1.20B | $1.16B | $1.10B | $1.02B | $709M | $663M | $519M | $356M | $265M | $205M | $183M | |
| Gross Profit | $2.71B | $2.80B | $2.71B | $2.63B | $2.94B | $1.76B | $1.74B | $1.45B | $1.12B | $815M | $640M | $578M | |
| R&D Expense | $370M | $364M | $347M | $305M | $250M | $175M | $157M | $129M | $98M | $76M | $61M | $53M | |
| SG&A Expense | $1.76B | $1.76B | $1.70B | $1.67B | $1.71B | $1.20B | $1.07B | $852M | · | · | $390M | $332M | |
| Operating Expenses | $2.17B | $2.19B | $2.06B | $1.99B | $1.96B | $1.38B | $1.20B | $981M | $763M | $566M | $451M | $385M | |
| Operating Income | $546M | $608M | $643M | $643M | $976M | $387M | $542M | $467M | $354M | $249M | $189M | $194M | |
| Interest Income | · | · | · | · | · | · | $12M | $9M | $7M | $4M | · | · | |
| Other Non-op | $23M | $-19M | $-19M | $-49M | $33M | $-11M | $8M | $-8M | $4M | $-11M | $-3M | $-3M | |
| Pretax Income | $585M | $609M | $641M | $599M | $1.01B | $379M | $563M | $467M | $365M | $243M | $186M | $190M | |
| Income Tax | $175M | $188M | $196M | $237M | $240M | $-1.40B | $112M | $58M | $130M | $51M | $42M | $45M | |
| Net Income | $410M | $421M | $445M | $362M | $772M | $1.78B | $443M | $400M | $231M | $190M | $144M | $146M | |
| EPS (Basic) | $5.66 | $5.63 | $5.82 | $4.62 | $9.78 | $22.55 | $5.57 | $5.00 | $2.89 | $2.38 | $1.80 | $1.81 | |
| EPS (Diluted) | $5.65 | $5.62 | $5.81 | $4.61 | $9.69 | $22.41 | $5.53 | $4.92 | $2.83 | $2.33 | $1.77 | $1.77 | |
| Shares (Basic) | 72,542,000 | 74,877,000 | 76,426,000 | 78,190,000 | 78,917,000 | 78,760,000 | 79,424,000 | 80,064,000 | 80,085,000 | 79,856,000 | 79,998,000 | 80,754,000 | |
| Shares (Diluted) | 72,588,000 | 74,993,000 | 76,568,000 | 78,420,000 | 79,670,000 | 79,230,000 | 80,100,000 | 81,357,000 | 81,832,000 | 81,484,000 | 81,521,000 | 82,283,000 | |
| EBITDA | $783M | $753M | $786M | $768M | $1.09B | $481M | $621M | $521M | $391M | $273M | $207M | $211M |
الميزانية العمومية
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.09B | $1.04B | $937M | $942M | $1.10B | $961M | $550M | $637M | $450M | $389M | $168M | $200M | |
| Short-term Investments | · | · | · | · | · | · | $318M | $98M | $272M | $251M | $360M | $255M | |
| Receivables | $1.10B | $996M | $903M | $860M | $897M | $658M | $550M | $439M | $324M | $247M | $159M | $130M | |
| Inventory | $226M | $254M | $297M | $339M | $230M | $139M | $112M | $56M | $32M | $27M | $19M | $16M | |
| Prepaid Expense | $166M | $199M | $274M | $226M | $195M | $92M | $102M | $72M | $81M | $38M | $27M | $20M | |
| Other Current Assets | $47M | $82M | $77M | $17M | $31M | $62M | $24M | $7M | · | · | · | · | |
| Current Assets | $2.62B | $2.49B | $2.45B | $2.42B | $2.49B | $1.85B | $1.63B | $1.30B | $1.16B | $953M | $732M | $657M | |
| PP&E (Net) | $1.13B | $1.27B | $1.29B | $1.23B | $1.08B | $735M | $632M | $521M | $349M | $175M | $136M | $90M | |
| PP&E (Gross) | $1.90B | $1.93B | $1.84B | $1.68B | $1.44B | $1.04B | $861M | $693M | $485M | $311M | $255M | $198M | |
| Accum. Depreciation | $767M | $662M | $551M | $450M | $359M | $301M | $230M | $172M | $136M | $136M | $118M | $108M | |
| Goodwill | $492M | $443M | $420M | $408M | $419M | $445M | $64M | $64M | $65M | $61M | $61M | $61M | |
| Intangibles | $94M | $103M | $82M | $96M | $110M | $130M | $12M | $18M | $24M | $21M | $18M | $21M | |
| Other Non-current Assets | $278M | $234M | $129M | $56M | $58M | $35M | $40M | $27M | $44M | $13M | $8M | $8M | |
| Total Assets | $6.23B | $6.21B | $6.08B | $5.95B | $5.94B | $4.83B | $2.50B | $2.05B | $1.78B | $1.40B | $1.16B | $988M | |
| Accounts Payable | $121M | $109M | $113M | $128M | $164M | $142M | $87M | $64M | $37M | $29M | $34M | $23M | |
| Accrued Liabilities | $537M | $598M | $526M | $454M | $607M | $406M | $320M | $235M | $196M | $134M | $108M | $88M | |
| Current Liabilities | $1.92B | $2.04B | $2.07B | $1.93B | $1.92B | $1.33B | $971M | $692M | $500M | $354M | $272M | $202M | |
| Capital Leases | $83M | $88M | $97M | $100M | $103M | $64M | $43M | $0 | · | · | · | · | |
| Other Non-current Liabilities | $114M | $140M | $173M | $196M | $175M | $100M | $37M | $29M | $16M | $1M | $2M | $3M | |
| Total Liabilities | $2.18B | $2.36B | $2.45B | $2.35B | $2.32B | $1.60B | $1.15B | $800M | $630M | $401M | $311M | $235M | |
| Common Stock | $7.0K | $7.0K | $7.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | |
| Paid-in Capital | $1.51B | $1.36B | $1.16B | $1.04B | $999M | $975M | $907M | $878M | $886M | $865M | $822M | $783M | |
| Retained Earnings | $2.46B | $2.48B | $2.45B | $2.57B | $2.62B | $2.22B | $440M | $378M | $267M | $131M | $27M | $-31M | |
| AOCI | $75M | $6M | $21M | $-10M | $4M | $44M | $-688.0K | $-3M | $571.0K | $-938.0K | $-980.0K | $-140.0K | |
| Stockholders' Equity | $4.05B | $3.85B | $3.63B | $3.60B | $3.62B | $3.23B | $1.35B | $1.25B | $1.15B | $999M | $848M | $753M | |
| Liabilities + Equity | $6.23B | $6.21B | $6.08B | $5.95B | $5.94B | $4.83B | $2.50B | $2.05B | $1.78B | $1.40B | $1.16B | $988M | |
| Shares Outstanding | 71,364,000 | 73,849,000 | 75,075,000 | 77,267,000 | 78,710,000 | 78,860,000 | 78,433,000 | 79,778,000 | 80,040,000 | 79,553,000 | 79,500,000 | 80,205,000 |
التدفق النقدي
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $237M | $145M | $142M | $126M | $109M | $94M | $79M | $55M | $38M | $24M | $18M | $18M | |
| Stock-based Comp | $186M | $174M | $154M | $133M | $114M | $98M | $88M | $71M | $59M | $54M | $53M | $40M | |
| Deferred Tax | $33M | $26M | $-19M | $-39M | $15M | $-1.49B | $307.0K | $-16M | $18M | $-16M | $-11M | $4M | |
| Amort. of Intangibles | $19M | $19M | $16M | $16M | $17M | $13M | $6M | $6M | $6M | $3M | · | · | |
| Restructuring | · | $37M | $14M | $10M | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-274M | $-28M | $63M | $-13M | $162M | $186M | $137M | $45M | $93M | $-4M | $34M | $-2M | |
| Operating Cash Flow | $593M | $738M | $786M | $569M | $1.17B | $662M | $747M | $555M | $439M | $248M | $238M | $227M | |
| CapEx | $102M | $116M | $178M | $292M | $401M | $155M | $150M | $223M | $196M | $71M | $53M | $24M | |
| Investing Cash Flow | $-112M | $-255M | $-196M | $-213M | $-563M | $-232M | $-350M | $7M | $-251M | $73M | $-166M | $-202M | |
| Stock Issued | $22M | $25M | $27M | $26M | $26M | $20M | $18M | $17M | $14M | $14M | $11M | $18M | |
| Stock Repurchased | $466M | $353M | $592M | $435M | $375M | $0 | $400M | $300M | $104M | $96M | $102M | $98M | |
| Net Stock Activity | $-444M | $-328M | $-566M | $-409M | $-349M | $20M | $-382M | $-283M | $-89M | $-82M | $-90M | $-80M | |
| Financing Cash Flow | $-465M | $-356M | $-598M | $-502M | $-458M | $-31M | $-486M | $-369M | $-136M | $-96M | $-101M | $-66M | |
| Net Change in Cash | $51M | $106M | $-4M | $-158M | $139M | $410M | $-86M | $187M | $57M | $222M | $-32M | $-43M | |
| Taxes Paid | $135M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $491M | $623M | $608M | $277M | $771M | $507M | $598M | $331M | $243M | $177M | $185M | $203M |
الربحية
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.2% | 70.0% | 70.1% | 70.5% | 74.3% | 71.3% | 72.5% | 73.6% | 75.8% | 75.5% | 75.7% | 75.9% | |
| Operating Margin | 13.5% | 15.2% | 16.7% | 17.2% | 24.7% | 15.7% | 22.5% | 23.7% | 24.0% | 23.1% | 22.3% | 25.4% | |
| Net Margin | 10.2% | 10.5% | 11.5% | 9.7% | 19.5% | 71.8% | 18.4% | 20.3% | 15.7% | 17.6% | 17.0% | 19.1% | |
| Pretax Margin | 14.5% | 15.2% | 16.6% | 16.0% | 25.6% | 15.3% | 23.4% | 23.7% | 24.8% | 22.5% | 22.0% | 25.0% | |
| EBITDA Margin | 19.4% | 18.8% | 20.3% | 20.6% | 27.5% | 19.4% | 25.8% | 26.5% | 26.6% | 25.3% | 24.4% | 27.8% | |
| ROA | 6.6% | 6.9% | 7.4% | 6.1% | 14.3% | 48.4% | 19.4% | 20.9% | 14.6% | 14.8% | 13.4% | 16.0% | |
| ROE | 10.3% | 10.8% | 12.0% | 9.9% | 21.6% | 56.7% | 33.4% | 32.7% | 21.5% | 20.6% | 18.0% | 21.0% | |
| ROIC | 9.4% | 10.9% | 12.3% | 10.8% | 20.5% | 56.1% | 32.2% | 32.6% | 19.8% | 19.7% | 17.2% | 19.7% |
السيولة والملاءة
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.2 | 1.2 | 1.3 | 1.3 | 1.4 | 1.7 | 1.9 | 2.3 | 2.7 | 2.7 | 3.3 | |
| Quick Ratio | 1.1 | 1.0 | 0.9 | 0.9 | 1.0 | 1.2 | 1.5 | 1.7 | 2.1 | 2.5 | 2.5 | 2.9 |
الكفاءة
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.7 | 0.6 | 0.6 | 0.7 | 0.7 | 1.1 | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 | |
| Inventory Turnover | 5.5 | 4.4 | 3.6 | 3.9 | 5.5 | 5.6 | 7.9 | 11.9 | 12.1 | 11.4 | 11.6 | 12.3 | |
| Receivables Turnover | 3.8 | 4.2 | 4.4 | 4.3 | 5.1 | 4.1 | 4.9 | 5.2 | 5.2 | 5.3 | 5.9 | 6.3 |
لكل سهم
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $56.74 | $52.16 | $48.36 | $46.61 | $46.03 | $41.01 | $17.16 | $15.70 | $14.37 | $12.51 | $10.67 | $9.39 | |
| Revenue / Share | $55.59 | $53.33 | $50.44 | $47.62 | $49.61 | $31.20 | $30.05 | $24.17 | $18.01 | $13.25 | $10.37 | $9.26 | |
| Cash Flow / Share | $8.17 | $9.84 | $10.26 | $7.25 | $14.72 | $8.36 | $9.33 | $6.82 | $5.36 | $3.04 | $2.92 | $2.76 | |
| Cash / Share | $15.34 | $14.14 | $12.49 | $12.19 | $13.97 | $12.18 | $7.02 | $7.98 | $5.62 | $4.89 | $2.11 | $2.49 | |
| EPS (TTM) | $5.65 | $5.62 | $5.81 | $4.61 | $9.69 | $22.41 | $5.53 | $4.92 | $2.83 | $2.33 | $1.77 | $1.77 |
معدلات النمو
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 0.90% | 3.5% | 3.4% | -5.5% | 59.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 2.6% | 0.39% | 16.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 0.53% | -3.3% | 26.0% | -52.4% | -56.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 7.0% | -16.6% | -36.2% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -24.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -2.6% | -5.3% | 23.1% | -53.2% | -56.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 4.3% | -18.3% | -37.0% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -25.4% | · | · | · | · | · | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا)
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.03B | $4.00B | $3.86B | $3.73B | $3.95B | $2.47B | $2.41B | $1.97B | $1.47B | $1.08B | $845M | $762M | |
| Net Income TTM | $410M | $421M | $445M | $362M | $772M | $1.78B | $443M | $400M | $231M | $190M | $144M | $146M | |
| Market Cap | $11.14B | $15.40B | $20.57B | $16.30B | $51.73B | $42.14B | $21.89B | $16.71B | $17.78B | $7.65B | $5.24B | $4.48B | |
| P/E | 27.6 | 37.1 | 47.2 | 45.7 | 67.8 | 23.8 | 50.5 | 42.6 | 78.5 | 41.3 | 37.2 | 31.6 | |
| P/S | 2.8 | 3.9 | 5.3 | 4.4 | 13.1 | 17.0 | 9.1 | 8.5 | 12.1 | 7.1 | 6.2 | 5.9 | |
| P/B | 2.8 | 4.0 | 5.7 | 4.5 | 14.3 | 13.0 | 16.3 | 13.3 | 15.5 | 7.7 | 6.2 | 6.0 | |
| P / Tangible Book | 3.2 | 4.7 | 6.6 | 5.3 | 16.7 | 15.8 | · | · | · | · | · | · | |
| P / Cash Flow | 18.8 | 20.9 | 26.2 | 28.7 | 44.1 | 63.6 | 29.3 | 30.1 | 40.6 | 30.9 | 22.0 | 19.8 | |
| P / FCF | 22.7 | 24.7 | 33.8 | 58.9 | 67.1 | 83.1 | 36.6 | 50.4 | 73.2 | 43.2 | 28.4 | 22.1 | |
| Earnings Yield | 3.6% | 2.7% | 2.1% | 2.2% | 1.5% | 4.2% | 2.0% | 2.4% | 1.3% | 2.4% | 2.7% | 3.2% |
قائمة الدخل
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.06B | $1.04B | $1.05B | $996M | $1.01B | $979M | $995M | $978M | $1.03B | $997M | $957M | $960M | $1.00B | $943M | $902M | $890M | |
| Cost of Revenue | $299M | $304M | $364M | $356M | $304M | $299M | $298M | $296M | $306M | $300M | $287M | $297M | $289M | $282M | $284M | $271M | |
| Gross Profit | $757M | $737M | $684M | $639M | $708M | $680M | $697M | $682M | $723M | $698M | $670M | $663M | $714M | $661M | $618M | $619M | |
| R&D Expense | $102M | $99M | $83M | $93M | $96M | $97M | $95M | $85M | $92M | $92M | $82M | $89M | $88M | $87M | $84M | $77M | |
| SG&A Expense | $463M | $465M | $442M | $418M | $449M | $448M | $425M | $434M | $452M | $452M | $403M | $408M | $453M | $440M | $410M | $399M | |
| Operating Expenses | $603M | $595M | $528M | $543M | $545M | $549M | $553M | $519M | $576M | $544M | $498M | $497M | $542M | $527M | $505M | $476M | |
| Operating Income | $154M | $142M | $155M | $96M | $163M | $131M | $144M | $162M | $147M | $154M | $172M | $166M | $172M | $134M | $113M | $144M | |
| Other Non-op | $-10M | $3M | $17M | $-5M | $8M | $4M | $-12M | $-371.0K | $-6M | $-141.0K | $-4M | $-10M | $-5M | $-1M | $-100.0K | $-23M | |
| Pretax Income | $149M | $149M | $177M | $95M | $174M | $140M | $141M | $166M | $144M | $158M | $173M | $162M | $172M | $135M | $115M | $123M | |
| Income Tax | $40M | $36M | $41M | $38M | $49M | $47M | $37M | $50M | $47M | $53M | $49M | $41M | $60M | $47M | $74M | $50M | |
| Net Income | $108M | $113M | $136M | $57M | $125M | $93M | $104M | $116M | $97M | $105M | $124M | $121M | $112M | $88M | $42M | $73M | |
| EPS (Basic) | $1.51 | $1.58 | $1.89 | $0.78 | $1.72 | $1.27 | $1.40 | $1.55 | $1.28 | $1.40 | $1.63 | $1.59 | $1.46 | $1.14 | $0.54 | $0.93 | |
| EPS (Diluted) | $1.51 | $1.57 | $1.88 | $0.78 | $1.72 | $1.27 | $1.40 | $1.55 | $1.28 | $1.39 | $1.63 | $1.58 | $1.46 | $1.14 | $0.54 | $0.93 | |
| Shares (Basic) | 71,495,000 | 71,425,000 | · | 72,377,000 | 72,565,000 | 73,562,000 | · | 74,736,000 | 75,184,000 | 75,175,000 | · | 76,569,000 | 76,524,000 | 76,921,000 | · | 78,093,000 | |
| Shares (Diluted) | 71,520,000 | 71,614,000 | · | 72,419,000 | 72,593,000 | 73,615,000 | · | 74,757,000 | 75,223,000 | 75,322,000 | · | 76,826,000 | 76,689,000 | 77,111,000 | · | 78,237,000 | |
| EBITDA | $194M | $199M | · | $152M | $204M | $170M | · | $200M | $183M | $187M | · | $203M | $208M | $169M | · | $176M |
الميزانية العمومية
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.10B | $1.06B | $1.09B | $1.00B | $901M | $873M | $1.04B | $1.04B | $761M | $866M | · | $1.24B | $952M | $832M | · | $1.04B | |
| Receivables | $1.15B | $1.13B | $1.10B | $1.10B | $1.12B | $1.06B | $996M | $1.01B | $1.02B | $951M | · | $904M | $908M | $884M | · | $860M | |
| Inventory | $212M | $215M | $226M | $228M | $244M | $247M | $254M | $254M | $259M | $280M | · | $296M | $313M | $312M | · | $321M | |
| Prepaid Expense | $200M | $216M | $166M | $174M | $187M | $220M | $199M | $291M | $351M | $350M | · | $218M | $237M | $252M | · | $229M | |
| Other Current Assets | $52M | $57M | $47M | $57M | $57M | $83M | $82M | $69M | $71M | $70M | · | $34M | $23M | $23M | · | $47M | |
| Current Assets | $2.66B | $2.66B | $2.62B | $2.53B | $2.45B | $2.40B | $2.49B | $2.60B | $2.41B | $2.48B | · | $2.70B | $2.47B | $2.33B | · | $2.50B | |
| PP&E (Net) | $1.11B | $1.11B | $1.13B | $1.18B | $1.26B | $1.26B | $1.27B | $1.29B | $1.28B | $1.28B | · | $1.27B | $1.28B | $1.26B | · | $1.20B | |
| PP&E (Gross) | · | · | $1.90B | · | · | · | $1.93B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $767M | · | · | · | $662M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $497M | $503M | $492M | $492M | $491M | $458M | $443M | $472M | $454M | $458M | $420M | $404M | $415M | $414M | $408M | $378M | |
| Intangibles | $95M | $101M | $94M | $99M | $103M | $103M | $103M | $116M | $116M | $121M | · | $83M | $89M | $93M | · | $92M | |
| Other Non-current Assets | $453M | $365M | $278M | $254M | $251M | $239M | $234M | $200M | $198M | $122M | · | $132M | $138M | $54M | · | $52M | |
| Total Assets | $6.42B | $6.31B | $6.23B | $6.23B | $6.22B | $6.10B | $6.21B | $6.37B | $6.16B | $6.16B | · | $6.32B | $6.14B | $5.90B | · | $5.91B | |
| Accounts Payable | $110M | $124M | $121M | $126M | $114M | $125M | $109M | $109M | $106M | $117M | · | $100M | $110M | $131M | · | $139M | |
| Accrued Liabilities | $612M | $547M | $537M | $546M | $563M | $546M | $598M | $575M | $555M | $497M | · | $614M | $600M | $497M | · | $384M | |
| Current Liabilities | $1.91B | $1.91B | $1.92B | $1.97B | $2.00B | $1.99B | $2.04B | $2.06B | $2.04B | $2.02B | · | $2.12B | $2.11B | $2.00B | · | $1.81B | |
| Capital Leases | $87M | $83M | $83M | $87M | $90M | $86M | $88M | $96M | $98M | $95M | · | $99M | $105M | $99M | · | $97M | |
| Other Non-current Liabilities | $120M | $108M | $114M | $112M | $117M | $131M | $140M | $150M | $158M | $156M | · | $179M | $181M | $191M | · | $185M | |
| Total Liabilities | $2.19B | $2.16B | $2.18B | $2.28B | $2.31B | $2.31B | $2.36B | $2.42B | $2.40B | $2.40B | · | $2.52B | $2.51B | $2.42B | · | $2.22B | |
| Common Stock | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | · | $8.0K | $8.0K | $8.0K | · | $8.0K | |
| Paid-in Capital | $1.57B | $1.53B | $1.51B | $1.48B | $1.43B | $1.39B | $1.36B | $1.34B | $1.28B | $1.24B | · | $1.19B | $1.14B | $1.10B | · | $1.06B | |
| Retained Earnings | $2.60B | $2.55B | $2.46B | $2.42B | $2.43B | $2.39B | $2.48B | $2.57B | $2.46B | $2.50B | · | $2.61B | $2.49B | $2.37B | · | $2.67B | |
| AOCI | $67M | $70M | $75M | $65M | $61M | $18M | $6M | $36M | $25M | $18M | · | $2M | $11M | $2M | · | $-41M | |
| Stockholders' Equity | $4.23B | $4.15B | $4.05B | $3.96B | $3.91B | $3.79B | $3.85B | $3.94B | $3.76B | $3.76B | $3.63B | $3.80B | $3.64B | $3.48B | $3.60B | $3.69B | |
| Liabilities + Equity | $6.42B | $6.31B | $6.23B | $6.23B | $6.22B | $6.10B | $6.21B | $6.37B | $6.16B | $6.16B | · | $6.32B | $6.14B | $5.90B | · | $5.91B | |
| Shares Outstanding | 71,245,000 | 71,617,000 | 71,364,000 | 72,040,000 | 72,486,000 | 73,057,000 | 73,849,000 | 74,757,000 | 74,696,000 | 75,281,000 | · | 76,588,000 | 76,532,000 | 76,516,000 | · | 78,111,000 |
التدفق النقدي
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $40M | $57M | $102M | $56M | $41M | $39M | $38M | $38M | $36M | $33M | $34M | $37M | $36M | $36M | $34M | $32M | |
| Stock-based Comp | $46M | $41M | $44M | $48M | $48M | $45M | $39M | $49M | $47M | $39M | $39M | $40M | $38M | $38M | $35M | $33M | |
| Deferred Tax | $-9M | $41M | $42M | $-9M | $-34M | $34M | $8M | $8M | $-9M | $18M | $4M | $14M | $-18M | $-18M | $-46M | $-8M | |
| Amort. of Intangibles | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Restructuring | · | · | · | $32M | $-100.0K | $2M | $37M | $0 | $-357.0K | $14M | $14M | · | $100.0K | $10M | $10M | · | |
| Other Non-cash | · | $-100M | · | · | · | $-158M | · | · | · | $-166M | · | · | · | $57M | · | · | |
| Operating Cash Flow | $193M | $151M | $223M | $189M | $129M | $53M | $286M | $264M | $160M | $29M | $47M | $287M | $252M | $200M | $145M | $266M | |
| CapEx | $36M | $31M | $36M | $20M | $21M | $25M | $23M | $30M | $53M | $9M | $33M | $22M | $59M | $64M | $53M | $75M | |
| Investing Cash Flow | $-82M | $-132M | $-36M | $-20M | $-31M | $-25M | $-54M | $-9M | $-112M | $-80M | $-13M | $-4M | $-125M | $-53M | $-56M | $-85M | |
| Stock Issued | $0 | $12M | $0 | $8M | $0 | $14M | $0 | $11M | $0 | $14M | $0 | $12M | $0 | $14M | $0 | $11M | |
| Stock Repurchased | $67M | $31M | $97M | $72M | $96M | $201M | $203M | $0 | $150M | $0 | $300M | $0 | $0 | $292M | $160M | $0 | |
| Net Stock Activity | · | $-19M | · | · | · | $-187M | · | · | · | $14M | · | · | · | $-278M | · | · | |
| Financing Cash Flow | $-67M | $-48M | $-97M | $-64M | $-96M | $-207M | $-203M | $11M | $-152M | $-12M | $-350M | $12M | $-931.0K | $-259M | $-200M | $11M | |
| Net Change in Cash | $43M | $-35M | $90M | $103M | $28M | $-171M | $2M | $281M | $-104M | $-72M | $-301M | $287M | $120M | $-110M | $-102M | $167M | |
| Free Cash Flow | · | $120M | · | · | · | $27M | · | · | · | $19M | · | · | · | $136M | · | · |
الربحية
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 71.7% | 70.8% | · | 64.2% | 69.9% | 69.5% | · | 69.7% | 70.3% | 70.0% | · | 69.1% | 71.2% | 70.0% | · | 69.5% | |
| Operating Margin | 14.6% | 13.7% | · | 9.7% | 16.1% | 13.4% | · | 16.6% | 14.3% | 15.4% | · | 17.3% | 17.2% | 14.2% | · | 16.1% | |
| Net Margin | 10.2% | 10.8% | · | 5.7% | 12.3% | 9.5% | · | 11.9% | 9.4% | 10.5% | · | 12.7% | 11.2% | 9.3% | · | 8.2% | |
| Pretax Margin | 14.1% | 14.3% | · | 9.5% | 17.1% | 14.3% | · | 17.0% | 14.0% | 15.9% | · | 16.9% | 17.1% | 14.3% | · | 13.8% | |
| EBITDA Margin | 18.4% | 19.1% | · | 15.3% | 20.1% | 17.4% | · | 20.5% | 17.8% | 18.8% | · | 21.2% | 20.7% | 17.9% | · | 19.8% | |
| ROA | 1.7% | 1.8% | · | 0.90% | 2.0% | 1.5% | · | 1.8% | 1.6% | 1.7% | · | 2.0% | 1.9% | 1.5% | · | 1.3% | |
| ROE | 2.7% | 2.8% | · | 1.4% | 3.2% | 2.5% | · | 3.0% | 2.6% | 2.9% | · | 3.2% | 3.1% | 2.5% | · | 2.0% | |
| ROIC | 2.6% | 2.6% | · | 1.5% | 3.0% | 2.3% | · | 2.9% | 2.6% | 2.7% | · | 3.3% | 3.1% | 2.5% | · | 2.3% |
السيولة والملاءة
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | · | 1.3 | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.2 | · | 1.4 | |
| Quick Ratio | 1.2 | 1.1 | · | 1.1 | 1.0 | 1.0 | · | 1.0 | 0.9 | 0.9 | · | 1.0 | 0.9 | 0.9 | · | 1.1 |
الكفاءة
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 1.3 | 1.3 | · | 1.5 | 1.2 | 1.1 | · | 1.1 | 1.1 | 1.0 | · | 1.0 | 0.9 | 1.0 | · | 1.0 | |
| Receivables Turnover | 0.9 | 1.0 | · | 0.9 | 0.9 | 1.0 | · | 1.0 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.0 | · | 1.0 |
لكل سهم
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $59.41 | $57.94 | · | $54.93 | $53.98 | $51.94 | · | $52.76 | $50.31 | $49.94 | · | $49.64 | $47.54 | $45.48 | · | $47.30 | |
| Revenue / Share | $14.77 | $14.52 | · | $13.75 | $13.95 | $13.30 | · | $13.08 | $13.67 | $13.24 | · | $12.50 | $13.07 | $12.23 | · | $11.38 | |
| Cash Flow / Share | · | $2.11 | · | · | · | $0.72 | · | · | · | $0.38 | · | · | · | $2.59 | · | · | |
| Cash / Share | $15.48 | $14.80 | · | $13.94 | $12.43 | $11.95 | · | $13.94 | $10.19 | $11.50 | · | $16.18 | $12.44 | $10.88 | · | $13.37 | |
| EPS (TTM) | $5.74 | $5.95 | · | $5.17 | $5.94 | $5.50 | · | $5.85 | $5.88 | $6.06 | · | $4.72 | $4.07 | $4.05 | · | $6.46 |
التقييم (آخر 12 شهرًا)
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.14B | $4.10B | · | $3.98B | $3.96B | $3.98B | · | $3.96B | $3.94B | $3.92B | · | $3.81B | $3.74B | $3.70B | · | $3.86B | |
| Net Income TTM | $414M | $430M | · | $378M | $438M | $410M | · | $442M | $447M | $462M | · | $363M | $314M | $315M | · | $511M | |
| Market Cap | $12.02B | $12.28B | · | $9.02B | $13.72B | $11.61B | · | $19.01B | $18.03B | $24.69B | · | $23.38B | $27.06B | $25.57B | · | $16.18B | |
| P/E | 29.4 | 28.8 | · | 24.2 | 31.9 | 28.9 | · | 43.5 | 41.1 | 54.1 | · | 64.7 | 86.9 | 82.5 | · | 32.1 | |
| P/S | 2.9 | 3.0 | · | 2.3 | 3.5 | 2.9 | · | 4.8 | 4.6 | 6.3 | · | 6.1 | 7.2 | 6.9 | · | 4.2 | |
| P/B | 2.8 | 3.0 | · | 2.3 | 3.5 | 3.1 | · | 4.8 | 4.8 | 6.6 | · | 6.2 | 7.4 | 7.3 | · | 4.4 | |
| P / Tangible Book | 3.3 | 3.5 | · | 2.7 | 4.1 | 3.6 | · | 5.7 | 5.7 | 7.8 | · | 7.1 | 8.6 | 8.6 | · | 5.0 | |
| P / Cash Flow | · | 81.3 | · | · | · | 220.3 | · | · | · | 861.2 | · | · | · | 127.9 | · | · | |
| Earnings Yield | 3.4% | 3.5% | · | 4.1% | 3.1% | 3.5% | · | 2.3% | 2.4% | 1.8% | · | 1.6% | 1.1% | 1.2% | · | 3.1% |
أحدث فترة على اليسار · القيم الفارغة معروضة كـ ·
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
| المقياس | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| الإيرادات | $4.03B | $4.00B | $3.86B | $3.73B | $3.95B |
| هامش الربح الإجمالي % | 67.2% | 70.0% | 70.1% | 70.5% | 74.3% |
| هامش الربح التشغيلي % | 13.5% | 15.2% | 16.7% | 17.2% | 24.7% |
| صافي الدخل | $410M | $421M | $445M | $362M | $772M |
| EPS المخفف | $5.65 | $5.62 | $5.81 | $4.61 | $9.69 |
| المقياس | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| النسبة الحالية | 1.4 | 1.2 | 1.2 | 1.3 | 1.3 |
| النسبة السريعة | 1.1 | 1.0 | 0.9 | 0.9 | 1.0 |
| المقياس | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $491M | $623M | $608M | $277M | $771M |
الملاك المؤسسيون (13F) 750 مقدمي إقرار · $13.7B إجمالي · حتى تاريخ 30 سبتمبر، 2026
المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.
حائزون
750
القيمة المحتفظ بها
$13.7B
مراكز جديدة
72
المراكز الخارجة
81
النشاط المؤسسي — Q2 2026 مقابل الربع السابق
| مراكز جديدة | المراكز الخارجة | زيادة | انخفض | صافي التغير في الأسهم |
|---|---|---|---|---|
| 72 (-73 مقابل الربع السابق) | 81 (-2 مقابل الربع السابق) | 215 (-34 مقابل الربع السابق) | 289 (+61 مقابل الربع السابق) | +3.4M |
مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.
| مؤسسة | القيمة | الأسهم | % من 13F المتتبعة | النوع |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1277272490 | 8179779 | 9,31% | الأسهم |
| BlackRock, Inc. | $745370304 | 4419366 | 5,44% | الأسهم |
| VANGUARD CAPITAL MANAGEMENT LLC | $742325451 | 4401313 | 5,41% | الأسهم |
| FMR LLC | $684765036 | 4060032 | 4,99% | الأسهم |
| Capital International Investors | $682324318 | 4045561 | 4,98% | الأسهم |
| Capital World Investors | $577219454 | 3422385 | 4,21% | الأسهم |
| GOLDMAN SACHS GROUP INC | $568849702 | 3372760 | 4,15% | الأسهم |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $528203316 | 3131764 | 3,85% | الأسهم |
| STATE STREET CORP | $431518634 | 2558512 | 3,15% | الأسهم |
| GEODE CAPITAL MANAGEMENT, LLC | $378153032 | 2245315 | 2,76% | الأسهم |
| Ninety One UK Ltd | $372703280 | 2209791 | 2,72% | الأسهم |
| UBS Group AG | $358450738 | 2125286 | 2,61% | الأسهم |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $292369455 | 1733484 | 2,13% | الأسهم |
| DIMENSIONAL FUND ADVISORS LP | $242715391 | 1438900 | 1,77% | الأسهم |
| Invesco Ltd. | $238412210 | 1413567 | 1,74% | الأسهم |
| Ruane, Cunniff & Goldfarb L.P. | $197577600 | 1171455 | 1,44% | الأسهم |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $180736225 | 1071601 | 1,32% | الأسهم |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $180291468 | 1068964 | 1,31% | الأسهم |
| MORGAN STANLEY | $170994867 | 1013842 | 1,25% | الأسهم |
| NORGES BANK | $152573715 | 904623 | 1,11% | الأسهم |
| AQR CAPITAL MANAGEMENT LLC | $151163848 | 899731 | 1,10% | الأسهم |
| JPMORGAN CHASE & CO | $134654324 | 773182 | 0,98% | الأسهم |
| DISCIPLINED GROWTH INVESTORS INC /MN | $132090801 | 783178 | 0,96% | الأسهم |
| Senvest Management, LLC | $125709888 | 745345 | 0,92% | الأسهم |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $112686638 | 668129 | 0,82% | الأسهم |
| Swedbank AB | $111012012 | 658200 | 0,81% | الأسهم |
| BARCLAYS PLC | $108101615 | 640944 | 0,79% | الأسهم |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $107285353 | 625826 | 0,78% | الأسهم |
| Assenagon Asset Management S.A. | $106450265 | 631153 | 0,78% | الأسهم |
| VOYA INVESTMENT MANAGEMENT LLC | $105404604 | 624952 | 0,77% | الأسهم |
| DEUTSCHE BANK AG\ | $99778582 | 591596 | 0,73% | الأسهم |
| NORTHERN TRUST CORP | $94827567 | 562241 | 0,69% | الأسهم |
| BANK OF AMERICA CORP /DE/ | $93085478 | 551912 | 0,68% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $79759314 | 472900 | 0,58% | عقد خيار البيع |
| FEDERATED HERMES, INC. | $78222317 | 463787 | 0,57% | الأسهم |
| Bares Capital Management, Inc. | $76349389 | 609722 | 0,56% | الأسهم |
| Amundi | $73309080 | 434656 | 0,53% | الأسهم |
| BROWN ADVISORY INC | $69759715 | 413611 | 0,51% | الأسهم |
| DAVENPORT & Co LLC | $64891092 | 384745 | 0,47% | الأسهم |
| VANGUARD FIDUCIARY TRUST CO | $63304170 | 375336 | 0,46% | الأسهم |
| JENNISON ASSOCIATES LLC | $59641380 | 353619 | 0,43% | الأسهم |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $59357000 | 351934 | 0,43% | الأسهم |
| Bank of New York Mellon Corp | $57062230 | 338327 | 0,42% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $56163780 | 333000 | 0,41% | عقد خيار الشراء |
| Carmignac Gestion | $53495676 | 316832 | 0,39% | الأسهم |
| CITADEL ADVISORS LLC | $50443170 | 299082 | 0,37% | الأسهم |
| Resona Asset Management Co.,Ltd. | $49583874 | 291177 | 0,36% | الأسهم |
| KEYBANK NATIONAL ASSOCIATION/OH | $47572414 | 282061 | 0,35% | الأسهم |
| WELLS FARGO & COMPANY/MN | $47249188 | 280145 | 0,34% | الأسهم |
| Nearwater Capital Markets, Ltd | $45200880 | 268000 | 0,33% | الأسهم |
الناشطون والمالكون بنسبة 5%+ 2 حيازتان
المستثمرون الذين قدموا الجدول الزمني 13D لدى هيئة الأوراق المالية والبورصات — ملكية مستفيدة تزيد عن 5% مع نية التأثير على المُصدر (حصص الناشطين، حملات مجلس الإدارة، الاندماج والاستحواذ). يعرض كل صف أحدث حالة معروفة لمركز مقدم الطلب هذا.
| مقدم | مقدم | حصة | الحالة | الغرض | إيداع |
|---|---|---|---|---|---|
| Danaher Corporation ×3 إيداعات | 14 نوفمبر، 2013 | · | إيداع أولي | استثمار سلبي | SEC |
| 1. Danaher Corporation | 22 فبراير، 2011 | · | إيداع أولي | استثمار سلبي | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
المطلعون على الشركة 66 من المطلعين · مسؤولون 24 · مديرون 17
| مطلع | الدور | آخر نشاط | الأسهم المملوكة | مشتريات 12 شهرًا | مبيعات 12 شهرًا | صافي 12 شهرًا |
|---|---|---|---|---|---|---|
| Joseph M Hogan | President and CEO | 20 فبراير، 2026 M | 209270 | 0 | 0 | $0 |
| John Morici | EVP, CHIEF FINANCIAL OFFICER | 20 فبراير، 2026 M | 13536 | 0 | 1 | $-1508611 |
| Kenneth Arola | VP, Finance and CFO | 20 فبراير، 2013 C | 31682 | 0 | 0 | $0 |
| Julie Ann Coletti | EVP, CHIEF LEGAL & REGULATORY | 20 فبراير، 2026 M | 11445 | 0 | 0 | $0 |
| Stuart A Hockridge | EVP, GLOBAL HR | 20 فبراير، 2026 M | 14892 | 0 | 0 | $0 |
| Emory Wright | EVP, GLOBAL OPERATIONS | 20 فبراير، 2024 A | 8294 | 0 | 0 | $0 |
| Jennifer Olson | SVP & Mng Dir Cust Service | 6 نوفمبر، 2020 G | 2277 | 0 | 0 | $0 |
| Yuval Shaked | SVP & Mng Dir. Itero | 4 نوفمبر، 2020 S | 636 | 0 | 0 | $0 |
| Zelko Relic | SVp, R&D and CTO | 4 نوفمبر، 2020 S | 13716 | 0 | 0 | $0 |
| Markus Christof Sebstian | SVP & Mng Dir EMEA | 20 أكتوبر، 2020 M | 613 | 0 | 0 | $0 |
| Simon Beard | SVP and Mgng Director, EMEA | 27 أغسطس، 2020 S | 17670 | 0 | 0 | $0 |
| Vamsi Mohan Raj Pudipeddi | SVP, Chief Marketing Officer | 18 مايو، 2020 S | 0 | 0 | 0 | $0 |
| Sreelakshmi Kolli | SVP & Mng Dir Info Tech | 20 فبراير، 2020 M | 13409 | 0 | 0 | $0 |
| Raphael Pascaud | CMO & Bus. Dev. | 1 أكتوبر، 2019 M | 27156 | 0 | 0 | $0 |
| Julie Tay | SVP & Mng Dir. Asia Pacific | 8 مايو، 2019 S | 17746 | 0 | 0 | $0 |
| Christopher C. Puco | VP, No. American Sales | 30 نوفمبر، 2018 S | 0 | 0 | 0 | $0 |
| Lynn Pendergrass | VP, Americas | 20 مارس، 2017 A | · | 0 | 0 | $0 |
| Timothy A Mack | VP, Bus Dev | 20 فبراير، 2016 M | 0 | 0 | 0 | $0 |
| Jennifer Erfurth | VP, Global HR | 20 فبراير، 2016 A | 10760 | 0 | 0 | $0 |
| John Patrick Graham | VP, Mktg & CMO | 5 مايو، 2015 S | 0 | 0 | 0 | $0 |
| Richard M.L. Twomey | VP International | 30 أكتوبر، 2013 M | 4272 | 0 | 0 | $0 |
| Dana Cambra | VP, R&D | 18 يونيو، 2012 C | 4398 | 0 | 0 | $0 |
| Sheila K Tan | VP Marketing & CMO | 17 نوفمبر، 2011 C | 19523 | 0 | 0 | $0 |
| Afsaneh Azadeh | Chief Information Officer | 20 فبراير، 2008 A | · | 0 | 0 | $0 |
| Quentin S. Blackford | مدير | 27 أغسطس، 2026 A | · | 0 | 0 | $0 |
| Anne Myong | مدير | 20 مايو، 2026 A | 9830 | 0 | 0 | $0 |
| Mojdeh Poul | مدير | 20 مايو، 2026 A | 3553 | 0 | 0 | $0 |
| Kevin J Dallas | مدير | 20 مايو، 2026 A | 16168 | 0 | 0 | $0 |
| Britt J. Vitalone | مدير | 20 مايو، 2026 A | 1443 | 0 | 0 | $0 |
| Andrea Lynn Saia | مدير | 20 مايو، 2026 A | 17318 | 0 | 0 | $0 |
| Kevin T Conroy | مدير | 20 مايو، 2026 A | 3553 | 0 | 0 | $0 |
| Susan E Siegel | مدير | 20 مايو، 2026 A | 10723 | 0 | 0 | $0 |
| Joseph Lacob | مدير | 20 مايو، 2026 A | 135916 | 0 | 0 | $0 |
| MORROW GEORGE J | مدير | 20 مايو، 2026 M | 5036 | 0 | 0 | $0 |
| Raymond C Larkin JR | مدير | 20 مايو، 2026 A | 27454 | 0 | 0 | $0 |
| Warren S Thaler | مدير | 17 مايو، 2023 M | 31780 | 0 | 0 | $0 |
| Greg J Santora | مدير | 17 مايو، 2023 M | 11987 | 0 | 0 | $0 |
| Thomas M Prescott | مدير | 19 مايو، 2021 M | 54129 | 0 | 0 | $0 |
| David E Collins | مدير | 15 مايو، 2014 C | 25900 | 0 | 0 | $0 |
| Brian H Dovey | مدير | 19 مايو، 2004 A | 0 | 0 | 0 | $0 |
| DANAHER CORP /DE/ | مالك 10% | 13 نوفمبر، 2013 S | 3837132 | 0 | 0 | $0 |
| KLEINER PERKINS CAUFIELD & BYERS VIII LP | مالك 10% | 10 نوفمبر، 2004 J | 1492421 | 0 | 0 | $0 |
| Roger E George | · | 14 مايو، 2019 S | 11773 | 0 | 0 | $0 |
| David L White | · | 18 نوفمبر، 2016 G | 5913 | 0 | 0 | $0 |
| David C Nagel | · | 13 مايو، 2016 M | 30200 | 0 | 0 | $0 |
| Len Hedge | · | 20 فبراير، 2013 C | 55861 | 0 | 0 | $0 |
| Dan Scott Ellis | · | 19 نوفمبر، 2012 M | 3552 | 0 | 0 | $0 |
| Gil Laks | · | 24 فبراير، 2010 C | 9773 | 0 | 0 | $0 |
| Sonia Clark | · | 25 سبتمبر، 2008 C | 1806 | 0 | 0 | $0 |
| Darrell Zoromski | · | 20 أغسطس، 2008 C | 1647 | 0 | 0 | $0 |
| Kent H Bowen | · | 15 مايو، 2008 C | 84500 | 0 | 0 | $0 |
| Hossein Arjomand | · | 26 نوفمبر، 2007 C | 617 | 0 | 0 | $0 |
| Eldon M Bullington | · | 26 نوفمبر، 2007 C | 4967 | 0 | 0 | $0 |
| Michael J Henry | · | 1 مايو، 2007 S | 0 | 0 | 0 | $0 |
| Kelsey Wirth | · | 2 مايو، 2006 S | 1074022 | 0 | 0 | $0 |
| David Thrower | · | 10 أغسطس، 2005 M | 15980 | 0 | 0 | $0 |
| Brian Dovey | · | 25 مايو، 2005 A | · | 0 | 0 | $0 |
| Rok Sribar | · | 1 مارس، 2005 A | · | 0 | 0 | $0 |
| Robert D Mitchell | · | 22 فبراير، 2005 A | · | 0 | 0 | $0 |
| Patricia L Wadors | · | 22 فبراير، 2005 A | · | 0 | 0 | $0 |
| Cecilia Claudio | · | 22 فبراير، 2005 A | · | 0 | 0 | $0 |
| KPCB VIII ASSOCIATES LP | · | 10 نوفمبر، 2004 J | 86526 | 0 | 0 | $0 |
| Amir Abolfathi | · | 8 نوفمبر، 2004 M | 10334 | 0 | 0 | $0 |
| Jon Fjeld | · | 28 مايو، 2004 S | 108864 | 0 | 0 | $0 |
| Gordon Gund | · | 10 مايو، 2004 P | 68659 | 0 | 0 | $0 |
| Joe Breeland | · | 12 مارس، 2004 A | 53985 | 0 | 0 | $0 |
المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط
ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 84 صناديق مؤشرات متداولة
الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.
| صندوق | الوزن | الوحدات | حتى تاريخ | المصدر |
|---|---|---|---|---|
| KMID · Virtus ETF Trust II | 3,44% | 9273 NS | 31 يوليو، 2026 | N-PORT |
| PRNT · ARK ETF Trust | 1,58% | 5467 NS | 31 يوليو، 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,57% | 94083 SH | 2 أكتوبر، 2026 | يومي |
| RNIN · EA Series Trust | 1,09% | 11732 NS | 31 يوليو، 2026 | N-PORT |
| ALTL · Pacer Funds Trust | 0,90% | 4911 NS | 31 يوليو، 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,85% | 52527 NS | 31 يوليو، 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,70% | 376 NS | 31 يوليو، 2026 | N-PORT |
| SPHB · Invesco Exchange-Traded Fund Trust … | 0,62% | 41430 SH | 2 أكتوبر، 2026 | يومي |
| HIBL · Direxion Shares ETF Trust | 0,61% | 2712 NS | 31 يوليو، 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,52% | 6492 NS | 31 يوليو، 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,48% | 751 SH | 2 أكتوبر، 2026 | يومي |
| BKMC · BNY Mellon ETF Trust | 0,28% | 10766 NS | 31 يوليو، 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,28% | 235486 NS | 31 يوليو، 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,25% | 30473 NS | 31 يوليو، 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,24% | 990688 SH | 19 أغسطس، 2026 | يومي |
| RSP · Invesco Exchange-Traded Fund Trust | 0,19% | 1276314 SH | 2 أكتوبر، 2026 | يومي |
| VHT · VANGUARD WORLD FUND | 0,17% | 204512 SH | 19 أغسطس، 2026 | يومي |
| FHLC · FIDELITY COVINGTON TRUST | 0,17% | 32382 NS | 31 يوليو، 2026 | N-PORT |
| IYH · iShares Trust | 0,16% | 39100 SH | 11 سبتمبر، 2026 | يومي |
| ISCG · iShares Trust | 0,15% | 9672 SH | 11 سبتمبر، 2026 | يومي |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,15% | 12214 NS | 31 يوليو، 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,15% | 133009 NS | 31 يوليو، 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 0,15% | 2860 NS | 31 يوليو، 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0,14% | 1921 NS | 31 يوليو، 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,14% | 1560504 SH | 19 أغسطس، 2026 | يومي |
| VFQY · VANGUARD WELLINGTON FUND | 0,14% | 4009 SH | 19 أغسطس، 2026 | يومي |
| ESML · iShares Trust | 0,14% | 25829 SH | 11 سبتمبر، 2026 | يومي |
| CURE · Direxion Shares ETF Trust | 0,13% | 1311 NS | 31 يوليو، 2026 | N-PORT |
| IXJ · iShares Trust | 0,13% | 34914 SH | 11 سبتمبر، 2026 | يومي |
| IWS · iShares Trust | 0,10% | 100293 SH | 11 سبتمبر، 2026 | يومي |
| PEXL · Pacer Funds Trust | 0,10% | 295 NS | 31 يوليو، 2026 | N-PORT |
| WSML · iShares Trust | 0,10% | 4205 SH | 11 سبتمبر، 2026 | يومي |
| RECS · Columbia ETF Trust I | 0,09% | 32471 NS | 31 يوليو، 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 5016 SH | 2 أكتوبر، 2026 | يومي |
| VFVA · VANGUARD WELLINGTON FUND | 0,09% | 4336 SH | 19 أغسطس، 2026 | يومي |
| VFMF · VANGUARD WELLINGTON FUND | 0,08% | 3482 SH | 19 أغسطس، 2026 | يومي |
| IWR · iShares Trust | 0,07% | 274791 SH | 11 سبتمبر، 2026 | يومي |
| XOEF · iShares Trust | 0,06% | 83 SH | 11 سبتمبر، 2026 | يومي |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,04% | 424 NS | 31 يوليو، 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,04% | 15374 SH | 19 أغسطس، 2026 | يومي |
| DXUV · Dimensional ETF Trust | 0,04% | 1211 NS | 31 يوليو، 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,04% | 4965 NS | 31 يوليو، 2026 | N-PORT |
| HDUS · Lattice Strategies Trust | 0,03% | 417 NS | 31 يوليو، 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,03% | 96570 NS | 31 يوليو، 2026 | N-PORT |
| IVE · iShares Trust | 0,03% | 111147 SH | 11 سبتمبر، 2026 | يومي |
| IUSV · iShares Trust | 0,03% | 57946 SH | 11 سبتمبر، 2026 | يومي |
| DFUV · Dimensional ETF Trust | 0,03% | 27760 NS | 31 يوليو، 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,03% | 20398 SH | 2 أكتوبر، 2026 | يومي |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 40343 SH | 19 أغسطس، 2026 | يومي |
| DCOR · Dimensional ETF Trust | 0,03% | 5902 NS | 31 يوليو، 2026 | N-PORT |
| DSI · iShares Trust | 0,03% | 10314 SH | 11 سبتمبر، 2026 | يومي |
| IWD · iShares Trust | 0,03% | 148444 SH | 11 سبتمبر، 2026 | يومي |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,03% | 1793 SH | 2 أكتوبر، 2026 | يومي |
| TILT · FlexShares Trust | 0,03% | 3318 NS | 31 يوليو، 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,02% | 7096 SH | 2 أكتوبر، 2026 | يومي |
| DFAU · Dimensional ETF Trust | 0,02% | 15866 NS | 31 يوليو، 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,02% | 13476 SH | 2 أكتوبر، 2026 | يومي |
| VOO · VANGUARD INDEX FUNDS | 0,02% | 1729431 SH | 19 أغسطس، 2026 | يومي |
| VTI · VANGUARD INDEX FUNDS | 0,02% | 2161771 SH | 19 أغسطس، 2026 | يومي |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 10952 SH | 19 أغسطس، 2026 | يومي |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 5657 SH | 19 أغسطس، 2026 | يومي |
| ESGV · VANGUARD WORLD FUND | 0,02% | 15119 SH | 19 أغسطس، 2026 | يومي |
| TOPC · iShares Trust | 0,02% | 40 SH | 11 سبتمبر، 2026 | يومي |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,02% | 2055 SH | 2 أكتوبر، 2026 | يومي |
| DFUS · Dimensional ETF Trust | 0,02% | 21777 NS | 31 يوليو، 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,02% | 3372 NS | 31 يوليو، 2026 | N-PORT |
| XVV · iShares Trust | 0,02% | 762 SH | 11 سبتمبر، 2026 | يومي |
| SPUU · Direxion Shares ETF Trust | 0,02% | 251 NS | 31 يوليو، 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0,02% | 1595 NS | 31 يوليو، 2026 | N-PORT |
| IVV · iShares Trust | 0,02% | 839331 SH | 11 سبتمبر، 2026 | يومي |
| PBP · Invesco Exchange-Traded Fund Trust | 0,01% | 393 SH | 2 أكتوبر، 2026 | يومي |
| IWB · iShares Trust | 0,01% | 46084 SH | 11 سبتمبر، 2026 | يومي |
| IWV · iShares Trust | 0,01% | 18798 SH | 11 سبتمبر، 2026 | يومي |
| IYY · iShares Trust | 0,01% | 2819 SH | 11 سبتمبر، 2026 | يومي |
| HCMT · Direxion Shares ETF Trust | 0,01% | 464 NS | 31 يوليو، 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 87429 SH | 11 سبتمبر، 2026 | يومي |
| SPXL · Direxion Shares ETF Trust | 0,01% | 5207 NS | 31 يوليو، 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0,01% | 53 SH | 1 أكتوبر، 2026 | يومي |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 58076 SH | 19 أغسطس، 2026 | يومي |
| LGDX · Tidal Trust III | 0,01% | 71 NS | 31 يوليو، 2026 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | -0,16% | -24215 NS | 31 يوليو، 2026 | N-PORT |
| SLTY · Tidal Trust II | -2,76% | -3000 NS | 31 يوليو، 2026 | N-PORT |
| ISCB · iShares Trust | · | 3130 SH | 11 سبتمبر، 2026 | يومي |
| ISCV · iShares Trust | · | 8638 SH | 11 سبتمبر، 2026 | يومي |
ALGN توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
تصنيف · 25 محللين
شراء
السعر المستهدف الوسيط
$207.00
+44,0%
7 28,0%
شراء قوي
9 36,0%
شراء
8 32,0%
احتفاظ
1 4,0%
بيع
0 0,0%
بيع قوي
السعر المستهدف لمدة 12 شهرًا
14 محللين · 2026-10-02السعر المستهدف المتوسط $206.36 +43,6%
← أقل من جميع الأهداف
السعر الحالي $143.74
منخفض$170.00
المتوسط$206.36
مرتفع$235.00
مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع
أساس السنة المالية، الأسعار كما في إغلاق نهاية السنة المالية الأخيرة لكل شركة.
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| ALGN | $11.14B | 27.6 | 0.90% | 10.2% | 10.3% | 67.2% |
| MDLN | · | -4200.0 | 11.5% | 4.1% | 21.6% | 26.4% |
| SOLV | $13.75B | 8.9 | 0.86% | 18.7% | 35.8% | 53.5% |
| COO | $13.70B | 37.4 | 5.1% | 9.2% | 4.6% | 65.5% |
| LNTH | $4.30B | 19.5 | 0.50% | 15.2% | 20.7% | 61.1% |
| MMED | $3.71B | -10.2 | 14.2% | -10.7% | -9.3% | 54.2% |
| MMSI | $5.24B | 41.4 | 11.8% | 8.5% | 8.4% | 48.7% |
| HAE | $2.45B | 26.4 | -2.0% | 7.3% | 11.8% | 59.0% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | · |
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
آخر الأخبار أحدث العناوين التي تذكر هذه الشركة
إشارات التداول إشارات شراء/بيع حديثة مع سعر الدخول ونسبة المخاطرة/المكافأة
BLUECHIP_DIP
تم الخروج
مخاطر 1
مكافأة 2,08
دخول
$167.85
R:R 2,08
BLUECHIP_DIP
تم الخروج
مخاطر 1
مكافأة 1,79
دخول
$171.75
R:R 1,79
BLUECHIP_DIP
تم الخروج
مخاطر 1
مكافأة 1,85
دخول
$173.53
R:R 1,85
RANGE
منتهي
مخاطر 1
مكافأة 5,00
دخول
$167.23
R:R 5,00
لا توجد إشارة مفتوحة حاليًا — لا توجد بطاقة معبأة، وهذا أمر صادق.
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
اختر المقاييس التي تهمك — انقر فوق علامة + بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.
المصدر: إيداع SEC 10-Q بتاريخ أغسطس 5, 2026